By monika singh | 22 Jan, 2022
Market movers: Supriya Lifescience gets reality check; Hikal back in demand after 11 sessions
NEW DELHI: Recently-listed Supriya Lifescience, which surged more than 100 per cent in the last three weeks, got a reality check on Friday after the company said its profit fell sharply quarter-on-quarter.The stock plunged over 17 per cent after the company said its profits declined 32 per cent sequential. Revenue also saw a drop compared to the September quarter. However, year-on-year, both reven...
Live Comments
Anku3036 2023-01-30 22:38:20
Co is going to declare interim dividend that means results will be good.
Login & Reply Like(0) Dislike(0) Repost SpamAnku3036 2022-12-31 19:10:15
promoter increased .25% holdings last week
Login & Reply Like(0) Dislike(0) Repost SpamSEMU 2022-09-01 11:27:07
Wait for sudden hike in Hikal. Dear buy for great return, I promisey
Login & Reply Like(0) Dislike(0) Repost SpamPalkin 2022-08-29 18:17:12
no BuyBack coming.. Just wait for right time and take suoer entry
Login & Reply Like(0) Dislike(0) Repost SpamPreeti 2022-08-18 13:53:12
Hold Hikal target of Rs 290
Login & Reply Like(0) Dislike(0) Repost SpamSONAM 21 2022-08-12 13:24:35
It will not fall back will cross 300 soon. may be next week itself.
Login & Reply Like(0) Dislike(0) Repost SpamDEBT_FREE 2022-08-10 17:16:39
Hikal reported a loss of Rs 8.66 crs for 1q23..
Login & Reply Like(0) Dislike(0) Repost SpamQueen_Of_Futures1 2021-08-14 09:57:17
overrated stock now... dont buy at levels before correction
Login & Reply Like(0) Dislike(0) Repost Spam